COVID-19
Running on adrenaline: hospital pharmacists and burnout
John Evans discusses how pharmacy can find its new generation of leaders – and keep the existing ones in a profession under pressure In this episode of the AJP podcast, …
Health workers feel undervalued following pandemic
Health systems around the world are failing to adequately protect frontline workers Pharmacists, dentists, nurses, physiotherapists and doctors are struggling with the physical and psychological scars of the Covid-19 pandemic, …
Covid jabs likely ‘for the foreseeable future’
The need for Covid boosters won’t go away – but convincing Australians to be vaccinated is a challenge, says one expert Dr Paul Griffin, infectious diseases physician and microbiologist, told …
Research Roundup
Debbie Rigby rounds up the latest in research news Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk A systematic review and meta-analysis was performed to investigate …
Inflation busting measures may impact pharmacy spending
Pharmacy owners need to take steps to strengthen consumer loyalty combat the impacts of rising inflation, experts warn Community pharmacies are starting to see the combined effects of measures taken …
Leading doc steers patients to pharmacy for jabs
Former deputy chief medical officer Dr Nick Coatsworth has suggested pharmacy as the best place for the general public to get their flu and covid jabs, given the GP shortage …
RATs in the ranks: pharmacy and covid testing examined
Researchers take a look at the role of pharmacists in testing for Covid and supplying rapid antigen test kits during the Covid-19 pandemic This article is the third in a …
Covid jabs: why Aussies chose pharmacy
What did the general public really think about community pharmacy’s involvement in the Covid-19 vaccination rollout? Researchers from the University of Adelaide have looked into consumer perceptions of Covid-19 vaccination …
Higher earners turn to pharmacy for flu jab
Australians’ annual incomes appear to influence where they opt to receive an influenza vaccine, a NAB report reveals Community pharmacies are the destination of choice for flu shots for 30% …
ATAGI makes Moderna biavalent recommendation
Moderna’s Covid-19 biavalent BA.4/5 vaccine is being recommended for use as a booster adolescents and adults aged 12 years and older The Australian Technical Advisory Group on Immunisation (ATAGI) issued …
We got some key things wrong about long COVID
Here are five things we’ve learnt, writes Peter Wark, University of Newcastle In late 2020 as we hid from COVID behind the moat of “fortress Australia”, we started to hear …
Provisional approval for adolescent bivalent booster
Moderna’s bivalent Covid-19 vaccine (elasomeran and davesomeran) has been granted provisional approval for use as a booster in adolescents aged 12 years and older The vaccine is the second targeting …